Coronary Restenosis
Cardiovascular
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
CordisSELUTION SLR 014 DEB
Clinical Trials (1)
Total enrollment: 418 patients across 1 trials
SELUTION SLR™ 014 In-stent Restenosis
Start: Jul 2020Est. completion: Aug 2029418 patients
N/AActive Not Recruiting
Related Jobs in Cardiovascular
Embedded Software and System Test Engineer (H/F)
Cardiawave
Levallois-Perret, France (Hybrid)
Just now
Territory Sales Manager - Iowa / Nebraska
HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
23h ago
From $150K/yr
Associate Regional Clinical Consultant
Johnson & Johnson
Amersfoort, Utrecht, Netherlands
Yesterday
Medical Affairs Sr Scientist- Electrophysiology
Johnson & Johnson
Irvine, California, United States of America
Yesterday
$92K - $148K/yr
Labeling Operations Specialist
Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday
Physician Program Director, Great North
Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday
$132K - $212K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space